Advances in the treatment of coeliac disease: an immunopathogenic perspective. - Wikidata - awgldk - TriplyDB

Advances in the treatment of coeliac disease: an immunopathogenic perspective.

Advances in the treatment of coeliac disease: an immunopathogenic perspective.

http://www.wikidata.org/entity/Q38126789

about

Gliadin-Specific T-Cells Mobilized in the Peripheral Blood of Coeliac Patients by Short Oral Gluten Challenge: Clinical Applications Therapeutic approaches for celiac disease Distribution, classification, domain architectures and evolution of prolyl oligopeptidases in prokaryotic lineages.Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials Coeliac Disease - New Pathophysiological Findings and Their Implications for Therapy Analysis of Body Composition and Food Habits of Spanish Celiac Women.Current status of drugs in development for celiac disease.Are stem cells a potential therapeutic tool in coeliac disease?Gut Microbiota and Celiac Disease.Lack of immunogenicity of hydrolysed wheat flour in patients with coeliac disease after a short-term oral challenge.Selected Probiotic Lactobacilli Have the Capacity To Hydrolyze Gluten Peptides during Simulated Gastrointestinal Digestion.Concise Review: Cellular Therapies: The Potential to Regenerate and Restore Tolerance in Immune-Mediated Intestinal Diseases.Identification and characterization of intestinal lactobacilli strains capable of degrading immunotoxic peptides present in gluten.The production of a recombinant tandem single chain fragment variable capable of binding prolamins triggering celiac disease.Quality of Life of Celiac Patients in Brazil: Questionnaire Translation, Cultural Adaptation and Validation

P2860

Q26775020-E995DDE4-BA79-47FB-8C37-B83033F41AE6 Q26825413-41773C25-C7F3-4594-ADD8-5C6770CC549B Q35434067-F6C8E811-D81C-498C-B7DA-31D42C03D4B3 Q35580144-A3A3168E-0FAF-478B-AE5C-EA9C8998B0E2 Q35885793-23A5F2FB-BF46-4A11-AC9D-482248610784 Q35895022-75C3E355-E2A2-4AF5-BD28-83B96AB5EBCD Q38210088-C0DE2600-87C0-47ED-83BB-C91970BFB343 Q38289416-AE93B252-8F17-47AB-A770-37D6E4E5D922 Q38685400-78AA43EC-45AC-40A7-BCAB-F0F3883D2F79 Q38719873-C6B62004-BA95-4506-AA60-38DC70E0F326 Q38788626-A7E94573-ABAB-4F06-85F4-3505C4110D33 Q38789482-D0544A6D-9EC7-4355-A1F3-7D2943059BC2 Q46817256-65780BD5-5FAE-46AB-AD37-0124DD9AE2D2 Q55224091-5EDF14B2-E396-47AC-80A2-3672311E9A05 Q58702551-401BACC5-E1D2-4B97-8A23-34C1F2C58EB6

P2860

Advances in the treatment of coeliac disease: an immunopathogenic perspective.

http://www.wikidata.org/entity/Q38126789

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Advances in the treatment of coeliac disease: an immunopathogenic perspective.

@en

type

label

Advances in the treatment of coeliac disease: an immunopathogenic perspective.

@en

prefLabel

Advances in the treatment of coeliac disease: an immunopathogenic perspective.

@en

P1433

Q38126789-4B2D66FA-B7E6-41D2-9270-DA14F7F3A777

P1476

Q38126789-5D2423F1-00BD-42E3-9F5B-A7235BA4EB2D

P2093

Q38126789-07355C10-381B-48F4-83AC-FA319EC40EB7

Q38126789-1EF35725-335D-4E5D-8252-B9F9B33EA305

Q38126789-488FDE2F-BC41-4EB1-8CB0-13F6626FA9FF

P2860

Q38126789-004C1A96-E0DA-4CD3-842C-4B6B870CFDAC

Q38126789-02974E7B-D1D0-4EF7-A12B-23810B57852E

Q38126789-0B0A5F70-F586-451A-BE05-B63A271F0277

Q38126789-10FAD0D0-B499-4FFF-B018-08641FD13C4E

Q38126789-1F58485A-0A57-4294-AF04-9505182C0AFC

Q38126789-23920F02-1E12-4DD6-BA80-9AA61B171494

Q38126789-251A095A-8B2C-4801-AE16-AB3029EE233F

Q38126789-255BA3F7-D727-4D28-A985-DD0B4B3469C5

Q38126789-2754D68D-14F0-40C9-809B-5E59F8A627A1

Q38126789-2BEB9436-D843-4A4F-AE98-8E24B2E271F5

P2888

Q38126789-BB94F0E9-1571-4E19-BC70-B8864C9E34D5

P304

Q38126789-76AAB6BA-16C3-4B9E-9FE2-01F524B5857E

P31

Q38126789-04160E15-8B6C-43FA-B830-62E01705C6A3

P356

Q38126789-D5841065-D66E-43EB-B0D6-74D82DC57775

P407

Q38126789-90A02F31-5AA7-4700-A869-1CDE75527CDC

P433

Q38126789-898F5009-1A7E-4DE7-9E77-8B7106A6048C

P478

Q38126789-72BFC3E5-67C3-4328-BC05-5C19D9E8F033

P577

Q38126789-1439BEDA-E015-46F5-813F-61B1922407CD

P5875

Q38126789-C71A43EF-5B3F-46F4-BACD-5F5752BC5ACC

P698

Q38126789-57C37C27-347E-4440-9194-A6FEC9311B6E

P356

NRGASTRO.2013.141

P1433

Nature Reviews Gastroenterology & Hepatology

P1476

Advances in the treatment of coeliac disease: an immunopathogenic perspective.

@en

P2093

Katri Kaukinen

http://www.w3.org/2001/XMLSchema#string

Katri Lindfors

http://www.w3.org/2001/XMLSchema#string

Markku Mäki

http://www.w3.org/2001/XMLSchema#string

P2860

IL-15 triggers an antiapoptotic pathway in human intraepithelial lymphocytes that is a potential new target in celiac disease-associated inflammation and lymphomagenesis

Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3

The intestinal T cell response to alpha-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase

CCL25/CCR9 interactions regulate large intestinal inflammation in a murine model of acute colitis

A structural and immunological basis for the role of human leukocyte antigen DQ8 in celiac disease

Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease

Identification of tissue transglutaminase as the autoantigen of celiac disease

Fontolizumab in moderate to severe Crohn's disease: a phase 2, randomized, double-blind, placebo-controlled, multiple-dose study

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis

Reduced chemokine receptor 9 on intraepithelial lymphocytes in celiac disease suggests persistent epithelial activation

P2888

nrgastro.2013.141

P304

36-44

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NRGASTRO.2013.141

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2013-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

255689185

http://www.w3.org/2001/XMLSchema#string

P698

23917697

http://www.w3.org/2001/XMLSchema#string